A small placenta, clinically defined as one weighing below the 10th percentile for gestational age, results from problems with blood flow, placental development, or both. The causes range from common pregnancy complications like preeclampsia to lifestyle factors like smoking, and the consequences can include restricted fetal growth and low birth weight. Understanding what drives this condition helps explain why extra monitoring becomes important when it’s detected.
How Blood Flow Problems Shrink the Placenta
The most well-understood cause of a small placenta involves the blood vessels that supply it. Early in pregnancy, specialized cells from the developing placenta are supposed to invade and remodel the spiral arteries in the uterine wall, widening them dramatically to increase blood flow. In conditions like preeclampsia, this remodeling fails in 30% to 50% of the spiral arteries. The arteries that escape remodeling stay narrow and undilated, with diameters less than half of what they should be in a healthy pregnancy.
This matters because as the fetus grows, it demands progressively more blood flow. Narrow arteries can’t deliver enough, so the placenta becomes increasingly starved of oxygen. The resulting ischemia limits the placenta’s ability to grow and develop properly. It also triggers a cascade of vascular dysfunction in the mother, including elevated blood pressure, which further impairs blood delivery. Chronic hypertension that predates pregnancy creates a similar problem, restricting the blood supply the placenta needs to reach its full size.
Autoimmune and Clotting Disorders
Antiphospholipid syndrome, an autoimmune condition where the body produces antibodies that promote abnormal clotting, is one of the more dramatic causes of placental shrinkage. These antibodies trigger inflammation and damage to the blood vessels feeding the placenta, creating a prothrombotic environment where clots form in the small arteries of the placental bed. The clots cut off blood supply to patches of tissue, causing infarctions, which are essentially areas of the placenta that die.
In severe cases, these infarctions can be extensive. One well-documented case involved a placenta with infarcts covering roughly 70% of its tissue, resulting in a final weight below the 5th percentile at 25 weeks. The pattern typically involves damage to the spiral arteries, followed by widespread oxygen deprivation, followed by multiple infarctions that progressively destroy functional placental tissue. Women with a history of blood clots in these conditions consistently have lower placental and neonatal weights.
Smoking and Nicotine Exposure
Maternal smoking during pregnancy is considered the principal environmental cause of fetal growth restriction in developed countries, and the placenta is a direct target. Nicotine disrupts placental development through several overlapping mechanisms. It inhibits the invasion and migration of the cells responsible for establishing the connection between mother and fetus. It also suppresses a key growth factor that drives the formation of new blood vessels in the placenta.
Animal studies have mapped this damage in detail. Nicotine exposure causes disorganization of the vascular tree in the part of the placenta responsible for nutrient and gas exchange, with significantly less branching and reduced total capillary length compared to unexposed placentas. This vascular underdevelopment leads to increased oxygen deprivation within the placenta itself, creating a vicious cycle: fewer vessels mean less oxygen delivery, which further limits growth. The result is a smaller, less functional placenta that struggles to support fetal development.
Maternal Nutrition
Caloric intake during pregnancy has a direct, measurable effect on placental size. Research comparing women across different nutritional levels found that placentas in malnourished women weighed about 15% less than those in well-nourished women, with a consistent relationship between the mother’s postpartum weight and her placental weight. Women who received low caloric supplementation during pregnancy (fewer than 20,000 total supplemented calories) had placentas roughly 11% lighter than those who received higher supplementation, regardless of the specific type of food.
This relationship held even when protein intake was adequate, suggesting that overall caloric energy, not just protein, fuels placental growth. Importantly, the biochemical composition of the placenta didn’t change with malnutrition. The placenta was simply smaller. Researchers concluded that low placental weight was the single most important measurable factor in reducing birth weight in these populations.
Chromosomal Abnormalities
Certain genetic conditions in the fetus directly affect placental development. Trisomy 13, where the fetus carries an extra copy of chromosome 13, is associated with small placental volume and reduced placental blood vessel formation. Women carrying a fetus with trisomy 13 are also prone to developing preeclampsia in the second and third trimesters, compounding the effect on placental size. Other chromosomal abnormalities, including trisomy 18, have also been linked to abnormal placental growth patterns. In these cases, the placenta’s developmental blueprint itself is altered, limiting its growth potential from the earliest stages.
Infections During Pregnancy
Certain maternal infections, particularly the group known as TORCH infections, can interfere with placental and fetal development. Cytomegalovirus (CMV) is one of the better-studied examples. The virus infiltrates and crosses the placenta, and congenital CMV infection is associated with fetal growth restriction along with brain abnormalities, hearing loss, and microcephaly. The inflammation caused by infection can damage placental tissue and impair its ability to grow and transport nutrients effectively.
How a Small Placenta Is Detected
During pregnancy, placental size can’t be directly weighed, so clinicians rely on ultrasound-based estimates. Three-dimensional power Doppler imaging can calculate placental volume using a rotational technique that outlines the placenta at multiple angles. Beyond raw volume, this imaging also measures how well the placenta is supplied with blood by calculating vascularization and flow indices. When placental volume is adjusted for fetal size (creating what’s called a placental quotient), pregnancies complicated by conditions like gestational hypertension show significantly lower values.
More commonly, a small placenta is suspected when the fetus measures smaller than expected and Doppler ultrasound of the umbilical artery shows abnormal blood flow patterns. The resistance to flow in the umbilical artery reflects how well blood is moving through the placenta, and elevated resistance suggests the placenta isn’t functioning at full capacity.
What Happens When a Small Placenta Is Found
The monitoring approach depends on how severely blood flow is affected. When fetal growth restriction is identified with either normal or mildly elevated umbilical artery resistance but blood is still flowing forward throughout the cardiac cycle, surveillance typically involves once or twice weekly fetal monitoring starting at diagnosis. This usually means regular ultrasounds and heart rate monitoring to confirm the baby is tolerating the limited placental function.
If Doppler readings worsen and forward flow during the resting phase of the heartbeat disappears entirely, the situation becomes more urgent. At that point, inpatient monitoring or twice-weekly surveillance is generally recommended, with delivery timing based on how the baby responds. If blood flow actually reverses direction in the umbilical artery during the resting phase, which signals severe placental failure, inpatient management is the standard approach. The goal at every stage is to balance the risks of prematurity against the risks of leaving the baby in an environment where the placenta can no longer keep up with its needs.